Neurology Advisor | Practice Changing News for Clinicians
Neurology news, research and treatment studies for MS, epilepsy, dementia, stroke and other brain and CNS disorders and diseases.
Leqembi Monthly IV Maintenance Dosing Approved for Early …
23 hours ago · References: FDA approves Leqembi ® (lecanemab-irmb) IV maintenance dosing for the treatment of early Alzheimer’s disease. News release. Eisai Inc. January 26, 2025. https://www.prnewswire.com ...
Vagus Nerve Stimulation Improves Sleep Quality, Reduces …
23 hours ago · Transcutaneous auricular vagus nerve stimulation (taVNS) significantly reduced insomnia severity, according to a small, sham-controlled trial published in JAMA Network Open.. Investigators ...
AI in Patient Care: Majority of Americans Want Notification About …
23 hours ago · Significant demographic differences emerged. Women were more likely than men to value notification (mean score, 3.45 vs 3.32; P =.02). Age significantly influenced preferences, with older adults ...
Long COVID Neurologic Symptoms Impact Younger, Middle-Aged …
Jan 28, 2025 · Long COVID neurologic symptoms including fatigue, sleep disturbance, and executive function, were more common among adults aged 18 to 64 vs those aged 65 and older. Younger and middle-aged ...
Lecanemab SC Formulation Under Review for Early Alzheimer …
Jan 17, 2025 · References: FDA accepts Leqembi ® (lecanemab-irmb) Biologics License Application for subcutaneous maintenance dosing for the treatment of early Alzheimer’s disease. News release. Eisai. January ...
Long-Haul COVID and Neurologic Symptoms: What ... - Neurology …
Feb 11, 2022 · Several studies provide evidence for neurologic and neuropsychiatric morbidity during and after COVID-19 infection—a phenomenon known as “long-haul COVID.” 1 People with long-haul COVID are ...
News Archive - Neurology Advisor
Jan 23, 2025 · Average life expectancy for patients with dementia ranges from 8.9 years after diagnosis at a mean age of 60 years for women to 2.2 years at a mean age of 85 years for men.
Brain Atrophy Is a Risk Factor for Progression to Mild Cognitive ...
Dec 18, 2024 · A total of 185 participants (mean age, 55.4; women, 63%) were included in the study, of whom 60 experienced progression to mild cognitive impairment during the follow-up period (mean, 20.2 years).
Antiseizure Medication Administration May Not Be Linked to …
Nov 13, 2024 · Etiology and electrographic findings are linked to the use of antiseizure medications in patients with acute symptomatic seizures and epileptiform abnormalities; treatment with antiseizure ...